GlassScriptPhysician profile
Angela Antoine
NPI 1134192479
$1,318.37
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $223 · 2021: $43.66 · 2022: $12.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $214.98 | 2019-2020 | |
| Novo Nordisk INC | $200.19 | 2019-2020 | |
| Amgen INC. | $196.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $158.14 | 2019-2021 | |
| Pfizer INC. | $122.70 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $69.24 | 2019 | |
| Abbvie INC. | $59.42 | 2019 | |
| Lilly USA, LLC | $55.21 | 2019 | |
| Celgene Corporation | $33.82 | 2019 | |
| Merck Sharp & Dohme LLC | $30.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.17 | 2019 | |
| Amarin Pharma, INC. | $25.08 | 2020 | |
| Alexion Pharmaceuticals, INC. | $19.42 | 2019 | |
| Janssen Biotech, INC. | $17.51 | 2020 | |
| Currax Pharmaceuticals LLC | $15.61 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.43 | 2019 | |
| Sanofi Pasteur INC. | $15.12 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.00 | 2019 | |
| Abbott Laboratories | $12.53 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Antoine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.